Background. To investigate the association between metabolically associated steatotic liver disease (MASLD) and ischemic heart disease (IHD), focusing on the clinical aspects of their comorbidity. Materials and methods. Data from 110 patients with IHD were analyzed. MASLD was diagnosed using liver ultrasound and metabolic parameters. Correlation and regression analyses were conducted to evaluate the relationship between metabolic disturbances and IHD severity. Results. MASLD was identified in 77.3% of patients with IHD. The severity of liver steatosis correlated with C-reactive protein levels, HOMA-IR index, and the frequency of acute coronary events. Patients with severe steatosis were more likely to experience myocardial infarction and dyslipidemia. Conclusion. MASLD is a significant risk factor that exacerbates the course of IHD. Early diagnosis and correction of metabolic disorders are essential for improving the prognosis of patients with this comorbidity.
| Mualliflar | Махкамова , М, Нуриллаева, Н, Maxkamova , Munisaxon, Nurillayeva, Nargiza, Makhkamova , Munisakhon, Nurillayeva, Nargiza |
|---|---|
| Jurnal | O‘zbekiston кardiologiyasi |
| Nashr sanasi | 2024-12-30 |
| Jild | 1 |
| Son | 4 |
| Betlar | 221-227 |
| Til | Rus |
| DOI | 10.70626/cardiouz-2024-1-00025 |
DOI: 10.70626/cardiouz-2024-1-00025 · Maqolaning asl sahifasi
метаболически ассоциированная стеатозная болезнь печени, ишемическая болезнь сердца, коморбидность, инсулинорезистентность, дислипидемия, воспаление, метаболические нарушения, metabolically associated steatotic liver disease, ischemic heart disease, comorbidity, insulin resistance, dyslipidemia, inflammation, metabolic disorders, metabolik bog'liq steatotik jigar kasalligi, yurak ishemik kasalligi, komorbidlik, insulin qarshiligi, dislipidemiya, yallig'lanish, metabolik kasalliklar
Background. Peripartum cardiomyopathy (PPCM) is a rare but potentially life-threatening condition associated with heart failure after childbirth. Genetic factors, including the angiotensin-converting enzyme (ACE) gene…
Background. Chronic heart failure (CHF) often requires ongoing management, and patients with CHF face significant challenges related to self-care and self-management. This study aimed to assess the effectiveness of a…
Background. Heart failure with preserved ejection fraction (HFpEF) is a complex clinical condition, often associated with chronic kidney disease (CKD). The interplay between these two conditions remains underexplored…
Background. Arterial hypertension (AH) is a complex, multifactorial disease that significantly contributes to cardiovascular diseases. It is particularly prevalent in the Aral Sea region, where both genetic and…
Цель. Острый инфаркт миокарда (ОИМ) остается основной причиной заболеваемости и смерт- ности в мире. Влияние реваскуляризации миокарда на уровень нейрогормонов и гемодинамику у больных с ОИМ остается важной темой для…
Background: The study explores mechanisms of intradialytic hemodynamic instability, which remains a significant challenge in the management of chronic kidney disease patients undergoing hemodialysis. Understanding the…
Background. to evaluate the immediate clinical and angiographic success in patients with NSTEMI, who underwent percutaneous coronary intervention (PCI) with the installation of a new generation of resorbable scaffolds…
Background. The purpose of this study was to compare the tolerability, safety, and clinical efficacy of generic and original apixaban in patients with arterial hypertension (AH) and permanent non-valvular atrial…
Beating-heart continuous coronary perfusion (BHCCP) has been promoted as an alternative to the technique of cardioplegic arrest in valve surgery. Its potential advantage is the elimination of cardioplegia and the…
Background. Dissecting aortic aneurysm (DAA) remains a critical issue in modern medicine, characterized by complex clinical presentations that mimic various pathologies. The diagnosis is often challenging due to the…